Cost-effectiveness and cost-utility analysis of a nurse-led, transitional care model to improve care coordination for patients with cardiovascular diseases: results from the “Cardiolotse” study
Marie Coors (),
Wiebke Schüttig,
Katrin C. Reber,
Harald Darius,
Alfred Holzgreve,
Sebastian Karmann,
Anica Stürtz,
Rebecca Zöller,
Saskia Kropp,
Petra Riesner and
Leonie Sundmacher
Additional contact information
Marie Coors: Technical University of Munich
Wiebke Schüttig: Technical University of Munich
Katrin C. Reber: Health Services Management
Harald Darius: Vivantes–Netzwerk für Gesundheit GmbH
Alfred Holzgreve: Vivantes–Netzwerk für Gesundheit GmbH
Sebastian Karmann: Vivantes–Netzwerk für Gesundheit GmbH
Anica Stürtz: Health Services Management
Rebecca Zöller: Health Services Management
Saskia Kropp: Technical University of Munich
Petra Riesner: Health Services Management
Leonie Sundmacher: Technical University of Munich
The European Journal of Health Economics, 2025, vol. 26, issue 5, No 1, 697-710
Abstract:
Abstract Objective To assess the 12-month cost-effectiveness of the nurse-led transitional care program “Cardiolotse” (CL) for patients with cardiovascular diseases compared to usual care (UC). Methods A cost-effectiveness analysis (CEA) and cost-utility analysis (CUA) were conducted from the perspective of statutory health insurance (SHI), covering a time horizon of 12 months. Analyzed outcomes included the number of rehospitalizations and health-related quality of life (HRQoL). Total costs comprised program costs and the utilization of healthcare resources. Point estimates are presented as incremental cost-effectiveness ratios (ICERs) and incremental cost-utility ratios (ICURs). Sensitivity and subgroup analyses were conducted to illustrate uncertainty and provide insights into the impact mechanisms of the CL program. Results The study population consisted of 2550 patients, with 1256 allocated to the intervention group and 1294 to the control group. Patients who received support from CLs experienced fewer rehospitalizations and lower inpatient costs from an SHI perspective, compared to the UC group. HRQoL assessments indicated higher utility values for CL patients at the 12-month follow-up. Total program costs amounted to €1454.65 per patient. The CEA and CUA demonstrate that the CL program is dominant compared to UC from the SHI perspective. Conclusion Our study shows that the CL program not only reduces the number of rehospitalizations and costs but increases HRQoL, resulting in a dominant ICER and ICUR. Further research is necessary to evaluate longer periods of time, different levels of care intensity, and perspectives of different healthcare stakeholders. Trial registration German Clinical Trial Register DRKS00020424, 2020-06-18, retrospectively registered.
Keywords: Care coordination; Transitional care; Cardiovascular disease; Economic evaluation; Cost-effectiveness; Health-related quality of life (search for similar items in EconPapers)
JEL-codes: I19 (search for similar items in EconPapers)
Date: 2025
References: Add references at CitEc
Citations:
Downloads: (external link)
http://link.springer.com/10.1007/s10198-024-01734-7 Abstract (text/html)
Access to the full text of the articles in this series is restricted.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:spr:eujhec:v:26:y:2025:i:5:d:10.1007_s10198-024-01734-7
Ordering information: This journal article can be ordered from
http://www.springer. ... cs/journal/10198/PS2
DOI: 10.1007/s10198-024-01734-7
Access Statistics for this article
The European Journal of Health Economics is currently edited by J.-M.G.v.d. Schulenburg
More articles in The European Journal of Health Economics from Springer, Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ) Contact information at EDIRC.
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().